Appointments
Global integrated marketing and communications agency FINN Partners has appointed Sophie Taylor-Roberts as Managing Partner and UK Health Group Lead. Taylor-Roberts will lead the FINN UK Health Group in strengthening its reputation as a leading communications partner for the biopharma, medical device and health system sectors. She succeeds Julie Adrian, who returned to her role [...]
Global marketing and communications agency FINN Partners has appointed Julie Adrian as Managing Partner and UK Health Group Lead. In the newly created position, Adrian will report to Gil Bashe, Chair FINN Global Health and Purpose. She will also work closely with Fern Lazar, managing partner, FINN Global Health Practice Lead, and Chantal Bowman-Boyles, managing [...]
Simply Nootropics has announced the appointment of Dr Brian P Ramos as its in-house neuroscientist. Dr Ramos, who has a PhD in neuroscience from Yale School of Medicine and boasts over two decades of experience, is poised to significantly contribute to the Sydney and Auckland-based company's growth and innovation. He has dedicated his career to [...]
Quotient Sciences, a global pharmaceutical drug development and manufacturing accelerator, has appointed Thierry Van Nieuwenhove as its new CEO. Thierry succeeds Mark Egerton who, after 18 years of successfully leading Quotient as CEO, is retiring from executive life. As part of the leadership transition, the Company also announces that Wayne Hewett has been appointed as [...]
Emerus has appointed Dr Rachel George, a seasoned healthcare executive, as CMO of the company. Care provider Emerus is has announced the appointment of Dr Rachel George as its new chief medical officer. Dr George brings a wealth of expertise and a proven track record in creating and implementing operational, clinical and growth strategies within [...]
InSilicoTrials has appointed Dr Mark Lovern as chief platform officer of the firm which uses AI technology to accelerate the development of new drugs. With the digital transformation revolution reshaping various industries, the role of chief platform officer has become even more pivotal, InSilicoTrials said. Dr Lovern will combine his scientific knowledge of AI, machine [...]
Pheon Therapeutics, a UK company developing next generation antibody drug conjugates (ADCs) for hard-to-treat cancers, has appointed Arvin Yang, MD, PhD, as its chief medical officer. Dr Yang joins Pheon with over a decade of experience in leading therapeutic oncology products through early-stage clinical development and late-stage global registration trials at both Bristol Myers Squibb [...]
AI-powered, digital health platform HealthBook+, which empowers users to take ownership of their own health through guidance and early identification of conditions, has announced a new medical advisory board. The board brings together specialist clinicians with experience and expertise in a broad range of key fields including mental and behavioural health, paediatrics, concierge medicine, direct primary care, [...]
Biotech company AAX Biotech, specialising in innovative, patentable technologies for improving antibody-based medicines, has appointed Maria Lisa Knudsen as CEO. The appointment is expected to contribute to the company's growth and the development of its pioneering technologies. AAX Biotech is a Swedish startup biotech company aiming to solve unmet needs in developing next-generation antibody therapeutics. [...]
VivoSense, Inc. has announced the appointment of Colin Bower as CEO and a member of its Board of Directors. Bower will succeed Dudley Tabakin, who will continue with VivoSense as Chief Product Officer. VivoSense is an aend-to-end scientific solutions company developing novel digital endpoints from wearable sensor data. Bower said: “I’m delighted to join the [...]
